C07C 323/41
Y being a hydrogen or an acyclic carbon atom
C07C323/41 (Y being a hydrogen or an acyclic carbon atom) appears on 342 US grants and 294 published applications in this corpus.
Search patents in C07C- Granted patents
- 342
- Published applications
- 294
- Assignees
- 241
- Inventors
- 1,127
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 4 | 0 |
| 1990 | 5 | 0 |
| 1991 | 7 | 0 |
| 1992 | 13 | 0 |
| 1993 | 12 | 0 |
| 1994 | 15 | 0 |
| 1995 | 18 | 0 |
| 1996 | 14 | 0 |
| 1997 | 6 | 0 |
| 1998 | 13 | 0 |
| 1999 | 14 | 0 |
| 2000 | 7 | 0 |
| 2001 | 5 | 1 |
| 2002 | 13 | 11 |
| 2003 | 9 | 11 |
| 2004 | 8 | 16 |
| 2005 | 7 | 12 |
| 2006 | 9 | 19 |
| 2007 | 8 | 14 |
| 2008 | 7 | 16 |
| 2009 | 14 | 19 |
| 2010 | 16 | 19 |
| 2011 | 15 | 19 |
| 2012 | 12 | 10 |
| 2013 | 11 | 12 |
| 2014 | 13 | 10 |
| 2015 | 12 | 9 |
| 2016 | 8 | 7 |
| 2017 | 10 | 14 |
| 2018 | 1 | 3 |
| 2019 | 2 | 11 |
| 2020 | 2 | 10 |
| 2021 | 8 | 4 |
| 2022 | 4 | 5 |
| 2023 | 5 | 14 |
| 2024 | 4 | 11 |
| 2025 | 4 | 11 |
| 2026 | 7 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical29 Sep 2026US 12,746,202 B2National University Corporation Chiba University
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Multi-motif dendrons and their supramolecular structures and uses thereof9 Jun 2026US 12,649,830 B2The Governing Council of the University of Toronto
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Process for synthesizing lipids5 May 2026US 12,617,754 B2Bristol-Myers Squibb Company
- Amino acid-derived ceramide, synthesis method therefor and use thereof1 Oct 2026US 2026/0297018 A1Shenzhen Dikeman Biotechnology Co., Ltd.
- Trisulfide compound23 Jul 2026US 2026/0209199 A1Kyowa Pharma Chemical Co., Ltd.
- Small molecule inhibitors of bacterial toxins4 Jun 2026US 2026/0152470 A1Artizan Biosciences
- Methods and materials for modulating nrf2 pathway7 May 2026US 2026/0124310 A1President and Fellows of Harvard College
- Herbicidal composition containing difluorobutenoic acid amide compound8 Jan 2026US 2026/0007131 A1Ishihara Sangyo Kaisha, Ltd.
Most cited
By later US patents
- 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production83US 5,703,129 ABristol-Myers Squibb Company · 1997
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Neuropeptide Y5 receptor antagonists65US 6,329,395 B1Schering Corporation · 2001
- Prodrugs containing novel bio-cleavable linkers62US 8,357,723 B2Piramal Enterprises Limited and Apparao Satyam · 2013
- Heteroatom containing perfluoroalkyl terminated neopentyl glycols and compositions therefrom61US 4,946,992 ACiba-Geigy Corporation · 1990